Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.978 (4,445.45%)
Aug 1, 2025, 11:00 AM EDT
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $6.57 million as of August 1, 2025. Its market cap has decreased by -78.40% in one year.
Market Cap
6.57M
Enterprise Value
23.63M
Revenue
899.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 6.57M, an increase of 2,496.81%. That is a compound annual growth rate of 24.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 6.57M | -33.17% |
| Dec 31, 2024 | 9.83M | -38.42% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | 108.70M | 44.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.98M |
| Northwest Biotherapeutics | 351.67M |